What Is the Abbreviation of ITP in Terms of Diseases?

ITP is the abbreviation for idiopathic thrombocytopenic purpura, also known as primary thrombocytopenia or immune thrombocytopenia. It is a hemorrhagic disease caused by immune factors leading to the destruction and reduction of platelets. Clinically, it is mainly manifested as bleeding and is a relatively common disease, accounting for approximately one-third of hemorrhagic diseases.

1. Acute symptoms: Patients with primary immune thrombocytopenia experience acute onset, resulting in bleeding manifestations in multiple areas such as the skin and mucosa throughout the body. Especially in the distal limbs, skin bruises are most prominent, and in severe cases, the bruises can fuse and form blood blisters. If the patient's condition continues to worsen, blood blisters may also develop in the oral mucosa and tongue, accompanied by symptoms such as gingival and nasal bleeding. Only a few patients experience bleeding in the gastrointestinal tract and retina, but intracranial bleeding is uncommon. Acute symptoms are often self-limiting, but some patients may have a prolonged course and easily develop chronic symptoms.

2. Chronic symptoms: Chronic primary immune thrombocytopenia has a particularly insidious onset, and its bleeding symptoms are directly related to the platelet count. Only 30-40% of patients have no symptoms at the time of diagnosis. As the condition worsens, varying degrees of small skin bleeding points or bruises may occur, especially after scratching or trauma.

3. General fatigue: Many patients with primary immune thrombocytopenia who have had the disease for a long time may experience significant fatigue symptoms, with a few individuals experiencing particularly prominent symptoms. Considering that the etiology of the disease is related to viral infection and exhibits self-limiting characteristics, the main treatment approach is symptomatic under the guidance of a doctor using medications.